GURUFOCUS.COM » STOCK LIST » Basic Materials » Metals & Mining » Medgold Resources Corp (TSXV:MED) » Definitions » YoY EBITDA Growth

Medgold Resources (TSXV:MED) YoY EBITDA Growth : 77.78% (As of Sep. 2023)


View and export this data going back to 1982. Start your Free Trial

What is Medgold Resources YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Medgold Resources's YoY EBITDA Growth for the quarter that ended in Sep. 2023 was 77.78%.

Medgold Resources's EBITDA per Share for the three months ended in Sep. 2023 was C$-0.00.


Medgold Resources YoY EBITDA Growth Historical Data

The historical data trend for Medgold Resources's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medgold Resources YoY EBITDA Growth Chart

Medgold Resources Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 41.41 9.33 1.96 38.50 32.52

Medgold Resources Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.00 25.81 -5.26 9.09 77.78

Medgold Resources YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Medgold Resources's YoY EBITDA Growth for the fiscal year that ended in Dec. 2022 is calculated as:

YoY EBITDA Growth (A: Dec. 2022 )
=(EBITDA per Share (A: Dec. 2022 )-EBITDA per Share (A: Dec. 2021 ))/ | EBITDA per Share (A: Dec. 2021 ) |
=(-0.083--0.123)/ | -0.123 |
=32.52 %

Medgold Resources's YoY EBITDA Growth for the quarter that ended in Sep. 2023 is calculated as:

YoY EBITDA Growth (Q: Sep. 2023 )
=(EBITDA per Share (Q: Sep. 2023 )-EBITDA per Share (Q: Sep. 2022 )) / | EBITDA per Share (Q: Sep. 2022 )) |
=(-0.004--0.018)/ | -0.018 |
=77.78 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medgold Resources YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Medgold Resources's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Medgold Resources (TSXV:MED) Business Description

Traded in Other Exchanges
N/A
Address
200 Burrard Street, Suite 650, Vancouver, BC, CAN, V6C 3L6
Medgold Resources Corp is a Canada-based mineral exploration company. The Company is engaged in the acquisition and exploration of resource and precious base metal properties. The company's geographical segments include Canada, Serbia and Others. Its project consists of the Tlamino gold project which is located in the Serbo-Macedonian massif which is a north-south belt, extending southwards through Macedonia and Bulgaria and into Greece. The Tlamino project comprises two contiguous licenses namely Donje Lamino and Surlica-Dukat and Ljubata Project.